“One of the biggest challenges in 3D printing and bioprinting is that truly novel technologies rarely fit perfectly into existing frameworks. They often challenge established processes, definitions, and expectations.”

“In healthtech today, we are not just building solutions that improve patient care; we also have to prove their economic and operational value. Health systems are under intense financial pressure, with consolidation, centralized decision-making, and a shift toward leaner care settings. Supply chain stakeholders and value analysis committees have become decisive in determining what gets adopted. For innovators, this means that clinical impact alone is not enough, though still very important, of course. We must build solutions that work for patients as well as the surgeons and healthcare systems delivering their care.”